Transforming Clinical Trials in Skin Cancer Research: Exploring the Potential of Flexible and Innovative Designs
Journal of Investigative Dermatology · 2025
DOI: 10.1016/j.jid.2025.03.032 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Investigative Dermatology, 2025. Verfasst von Rainer Puhr und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Hauptthemen laut MEDLINE: Skin Neoplasms, Research Design, Clinical Trials as Topic, Melanoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Faculty of Information Technology, Monash University, Melanoma Institute Australia, Cancer Institute NSW.
Abstract (Originalsprache)
Over the past 2 decades, innovations in trial design have significantly advanced the field of clinical research. Methodological developments, such as adaptive designs, basket trials, umbrella trials, and platform trials, along with technological advancements such as virtual studies have proven effective in tackling complex research questions and managing resource constraints. These approaches enable prospectively planned modifications to trial designs and facilitate addressing multiple research questions within a single infrastructure, with technological advancements such as virtual studies enhancing accessibility, efficiency, and patient engagement. These designs can also integrate biomarker information or risk-prediction scores to enhance the efficacy of future clinical trials, through a better selection of patients. Despite the appealing flexibility of these new approaches, their adoption varies across different therapeutic domains. We explored the translation and relevance of these innovative approaches in skin cancer research with a focus on melanoma. An overview of existing melanoma clinical trials that incorporate innovative features as well as other potential studies currently under consideration are discussed. This paper highlights the potential of innovative approaches to optimize melanoma trials under the constraints of limited patient and financial resources. The presented ideas can easily be extended to other nonmelanoma skin cancer trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
- MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
- Institute of Academic Surgery, Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicin…
- Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Sydney, Australia; Charles Perkins Centre, The University of Sy…
Förderung
- Faculty of Information Technology, Monash University
- Melanoma Institute Australia
- Cancer Institute NSW
- National Health and Medical Research Council
Zitieren
APA
Puhr, R., Ryan, E. G., Couturier, D. L., van Akkooi, A. C. J., Pires da Silva, I., Heritier, S., & Lo, S. N. (2025). Transforming Clinical Trials in Skin Cancer Research: Exploring the Potential of Flexible and Innovative Designs. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2025.03.032
Vancouver
Puhr R, Ryan EG, Couturier DL, van Akkooi ACJ, Pires da Silva I, Heritier S, et al. Transforming Clinical Trials in Skin Cancer Research: Exploring the Potential of Flexible and Innovative Designs. Journal of Investigative Dermatology. 2025. doi:10.1016/j.jid.2025.03.032
BibTeX
@article{Puhr2025,
author = {Puhr, Rainer and Ryan, Elizabeth G and Couturier, Dominique-Laurent and van Akkooi, Alexander C J and Pires da Silva, Ines and Heritier, Stephane and Lo, Serigne N},
title = {Transforming Clinical Trials in Skin Cancer Research: Exploring the Potential of Flexible and Innovative Designs},
journal = {Journal of Investigative Dermatology},
year = {2025},
doi = {10.1016/j.jid.2025.03.032}
}
EUVIMED